Daily Brief Archive: July 17, 2026 — U.S. & Hong Kong Stock Analysis

Technicals — Closed at $853.20 through both the $880 stop and the 50-day ($930) on just 1.06x volume — day three came without a volume spike, which reads as orderly distribution, not a panic low. The 7-day RSI at 30.8 nears oversold; next support is the $800 round number and May shelf, with the 20-day far above at $1,033.

Fundamentals — The fundamentals didn't change — the other side of the trade did. HBM 2026 capacity is sold out with orders booked into 2027, but CXMT (the world's #4 DRAM maker at 7.7% share) just priced China's largest-ever semiconductor IPO at RMB 57.9B for a 7/27 listing — the China-capacity story graduated from rumor to prospectus. A single unverified report adds possible tighter US HBM export rules.

News — TSMC's capex raise to $60–64B triggered a sector-wide valuation scare with the SOX down ~4%. Morningstar warns AI names could give back 20–30% while BofA counter-raised SanDisk to a $2,500 target — the bull-bear split has never been this wide, and Buffett's 'everybody is gambling' line still tops the tape.

Technicals — Closed at $500.94 through the $518 stop, parking exactly on the 50-day at $496 — the last near support; failure there opens the $460 gap-fill. Volume was flat at 1.04x, and the weekly scissors versus NVIDIA (+0.33%) widened to eight points.

Fundamentals — No company-specific negative — which is precisely the problem: under the TSMC capex shock the market re-ranked the AI chain by pricing power, and AMD's share-for-margin MI playbook with hyperscalers gets treated as pure beta in a risk-off. With consensus at $539, just 7.6% above, the crowding was already spent.

News — Down 5.3% in the TSMC-capex panic alongside memory's third leg (Intel -4.4%, Marvell -8.7%, extending losses on capex fears a day after Erste's valuation downgrade). Its next self-defense comes at early-August earnings — until then, the signal ledger owes it no direction.

Technicals — Earnings day (7/16) opened with a ~4% premarket drop that narrowed into a -2.3% close at $409.74 — a sixth straight losing session. The 20-day ($439) and 50-day ($426) cap above, RSI sits at 42 with the week at -8.3% — a good company on a bad chart; the print proved the fundamentals, not the trend.

Fundamentals — 2nm contributed 3% of revenue for the first time, advanced nodes hit 77% of wafer sales, and full-year growth guidance rose past 40%. The price-hike matrix (3nm +15%, HPC/AI up to +10%, mature nodes from 2027) shows bargaining power expanding — the capex raise confirms demand; the market just chose to count costs before demand today.

News — Chairman C.C. Wei: 'confidence in the multi-year AI megatrend remains very high,' with the CFO citing the steep 2nm ramp behind Q3. But the capex shockwave became the day's sector-wide selloff trigger, SOX ~-4% — a monopolist's capex line is everyone else's cost sheet.

Technicals — Closed at $74.35 on the 20-day ($74.28), then traded near $69 after hours — tonight opens gapping below the 52-week low ($70.86). RSI 42 gets reset by the AH price, the post-split (10:1, Nov 2025) chart offers no historical support map, and the $70 round number is the only psychological anchor.

Fundamentals — Q2 itself wasn't bad: a 33% operating margin beat guidance and ad revenue tracks the doubling to ~$3B. But the full-year range narrowed, H1 watch time grew just 2%, and the company will disclose fewer engagement metrics — every step of the downshift from growth story to margin story gets paid for in multiple.

News — The AH print: revenue of $12.56B vs roughly $12.57B expected, EPS $0.80 vs $0.79, and a Q3 guide of $12.86B (+12%) against ~$13B hopes; the stock slid from -7.2% to -9.7% by the end of the call. Bloomberg's pre-earnings headline had already written the epitaph: 'earnings risk after a $257 billion wipeout.'

Technicals — Down 17% on 4.24x volume to $55.01, below every average (200-day at $83) with the $36 52-week low still 35% away. The 7-day RSI at 18.7 is extreme — but inside a three-day, 27% slope, 'oversold' is an adjective, not an entry.

Fundamentals — The convert terms aren't bad (1.625% coupon, +20% premium, a $149.20 capped call hedging dilution); the real wound is execution repricing — Blue Origin's New Glenn pre-launch static-fire explosion (vehicle and pad destroyed) pushed the 45-satellite BlueBird constellation to early 2027, shifting the entire commercial revenue timeline right. Rakuten's J-LEO project in Japan (potentially ~$1B) is the rare fresh positive on the slate.

News — The convert dropped after hours 7/15 (-13%) and the stock bled 17% through 7/16. The 8-K's 'acquiring additional orbital capacity' language sparked launcher-buyout speculation (analysts name ULA, Firefly, Relativity, Stoke; the company says no agreements). The same week, Piper Sandler initiated at Overweight with a $100 target — bull and bear timelines fully dislocated.

Technicals — Down 13.9% to $171.77, a 43% drawdown from June's $300 top. The 200-day at $137.52 is the next major support, a $24.75 ATR makes ±14% days routine, and while the 7-day RSI at 25.7 is oversold, a short base near a quarter of the float means any bounce can be a squeeze — no heavy bets in either direction.

Fundamentals — The growth-versus-cash race enters its dangerous stretch: $20–25B of 2026 capex against persistently negative operating cash flow, with new capacity earning nothing until early 2027. Even 7/14's $1B Reflection AI deal and 7/15's asset-light partnership couldn't stop the slide — when funding markets reprice AI infrastructure, the balance sheet becomes the valuation.

News — NY Governor Hochul's temporary ban on new large data centers (citing power prices and resources) — attacked by Trump on Truth Social — made policy risk tangible for the first time. Stacked on the TSMC capex shock, the neocloud trio (NBIS/CRWV/IREN) unraveled together, with CoreWeave carrying its own customer-turned-competitor Meta worry and a Mizuho target cut to $100.

Technicals — The fifth long red candle in six sessions closed at another 52-week low of $124.21. RSI 26.9 differs from the 7/14 oversold only in altitude — the 'wait for a decent doji' from last issue got its +3.6% candle on 7/15, and it lived exactly one day, proving the bounce was pure short-covering.

Fundamentals — The numbers keep deteriorating: FY26 capex of $55.7B (83% of revenue), FCF at -$23.7B, year-end debt near $156B (vs ~$87B a year earlier) and a $40B raise planned. BNP lifted its FY27 capex estimate from $72B to $83B in early June — latest talk runs $80–100B, another step above the company's own ~$70B net-capex guide — and the market only began pricing those numbers this week. With just 12% of backlog converting inside a year and ~50% concentrated in OpenAI, the word 'backlog' has lost its pricing power.

News — Bloomberg's 7/16 piece — 'Oracle Faces Credit Downgrade as AI Spending Outpaces Cash Flow' — landed while S&P's 7/9 cut to BBB- is still being digested; no new rating action on the day. This decline doesn't need news anymore, just compounding: -28% in a month, after late June's worst week since the dot-com bust.

Technicals — Down 0.9% to $391.06, a fourth day nailed just above the $390 stop. All three averages press from overhead (20-day $398.63, 50-day $409.97, 200-day $417.36) on 0.73x volume — neither side will act, ceding the decision to earnings week's first volume candle.

Fundamentals — The 7/22 suspense is still margin (was the 480k delivery quarter bought with cuts?) against a $0.27 EPS consensus. No new fundamental input this week — which is exactly the danger: price on the stop, an information vacuum and an imminent event combine every downside of waiting passively.

News — No company news; its -0.9% held up relatively well through the AI unwind, but resilience earns no prize 0.27% above a stop line.

Technicals — Up 1.8% to a record $334.68 intraday on 1.3x volume. RSI(14) at 71.4 runs hot — exactly how trend leaders behave. Nothing overhead; the $315 shelf and $308 MA cluster form double support below, ATR $8.30.

Fundamentals — The haven-plus-certainty repricing keeps unfolding: cash flow, buybacks and ecosystem lock-in get panic-bought on every AI scare, with StockTwits calling it a 'major safe-haven asset' outright. Consensus targets trail the price by 4.4% — the upgrade cycle is the most certain tailwind from here.

News — No company news; the entire +5.8% two-day run came from migration — money exiting fallen IBM, cratering memory and unwinding neoclouds needs a container big enough to hold it.

Technicals — Down 8.2% this morning at HK$118.20, through both the HK$122 stop and the 130 breakout shelf, back to the last cushion above the 20-day (HK$113.91). RSI collapsed from 70 to 54.9 — a breakout structure dissolving inside three days, the classic failed-breakout timestamp.

Fundamentals — The fundamental script didn't change — the CXO order recovery, the H-share incentive and HK$136 bank targets all stand. The positioning changed: a 20% three-day A-share deviation triggered an exchange review, Soochow's weekly showed it topping the sector at +19.85%, and half-year fund settlement found its fattest target.

News — The 7/15 A-share filing confirmed nothing undisclosed; HK pharma began pulling back 7/16 (this name -3.7%, Joinn -6%); this morning the slide accelerated. The three-day timeline points squarely at profit-taking, not a fundamental event — BIOSECURE became law in December 2025 and added nothing new this round.

Technicals — Down 1.6% this morning at HK$115.00, 0.8% back under the 50-day (HK$115.89). The RSI-7 at 73.7 bleeds off its heat into the dip; the HK$110 round number and gap form second support with the HK$108 stop beneath — structure intact, exam merely postponed.

Fundamentals — The ~45% cloud-growth preview and the Qwen 3.7 flagship suite (Qwen3.7-Max/Plus) keep the re-rating case unchanged. WAIC 2026 opens in Shanghai today (7/17–20) — a dense catalyst window that resupplies Alibaba's narrative, even as it turns 'news to sell' for the already-run AI model names like MiniMax.

News — No company news; with the Hang Seng opening lower on the US tape, its -1.6% ranks among the book's most resilient — week two of the AI re-rating, and the money hasn't left.

Technicals — Down 7.6% this morning at HK$236.60, just 12% above the HK$209 low six months post-listing. The 20-day (HK$367) and 50-day (HK$547) float in another postcode and RSI reads 31.5 — on a new listing 82% off its high, technical analysis offers one conclusion: no anchors, only positioning and mood.

Fundamentals — Three structural weights remain: the 48%+ share unlock still digesting, dilution from the HK$16B raise, and the muddled pricing — a half-price launch promo for M3 alongside quietly raised subscription tiers — exposing the model layer's pricing-power bind. The founder's zero salary, 4% team-incentive pledge and 1% open-source fund are gestures — and gestures don't reverse cash-flow direction.

News — 7/15's triple buy call from UBS/Goldman/CICC (JPMorgan stayed at 'hold' with a 240 target) drove a 13–15% pop toward HK$260; 7/16 drifted; this morning's -7.6% cashed the 'good news spent' cheque as WAIC 2026's opening day (7/17–20) became take-profit day — the same script as the 7/9 unlock: every catalyst is an exit window.